Drug
Prt060128
Prt060128: highest development phase Phase 2, developed by Alexion. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Alexion
Trials
| Drug | Phase | Indication |
|---|---|---|
| PRT060128 Potassium NCT00546260 | Phase 2 | Myocardial Infarction |
Latest
No recent events.
Follow Prt060128 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.